Literature DB >> 26244149

From variome to phenome: Pathogenesis, diagnosis and management of ectopic mineralization disorders.

Eva Yg De Vilder1, Olivier M Vanakker1.   

Abstract

Ectopic mineralization - inappropriate biomineralization in soft tissues - is a frequent finding in physiological aging processes and several common disorders, which can be associated with significant morbidity and mortality. Further, pathologic mineralization is seen in several rare genetic disorders, which often present life-threatening phenotypes. These disorders are classified based on the mechanisms through which the mineralization occurs: metastatic or dystrophic calcification or ectopic ossification. Underlying mechanisms have been extensively studied, which resulted in several hypotheses regarding the etiology of mineralization in the extracellular matrix of soft tissue. These hypotheses include intracellular and extracellular mechanisms, such as the formation of matrix vesicles, aberrant osteogenic and chondrogenic signaling, apoptosis and oxidative stress. Though coherence between the different findings is not always clear, current insights have led to improvement of the diagnosis and management of ectopic mineralization patients, thus translating pathogenetic knowledge (variome) to the phenotype (phenome). In this review, we will focus on the clinical presentation, pathogenesis and management of primary genetic soft tissue mineralization disorders. As examples of dystrophic calcification disorders Pseudoxanthoma elasticum, Generalized arterial calcification of infancy, Keutel syndrome, Idiopathic basal ganglia calcification and Arterial calcification due to CD73 (NT5E) deficiency will be discussed. Hyperphosphatemic familial tumoral calcinosis will be reviewed as an example of mineralization disorders caused by metastatic calcification.

Entities:  

Keywords:  Arterial calcification due to CD73 deficiency; Ectopic mineralization; Etiology; Generalized arterial calcification of infancy; Hyperphosphatemic familial tumoral calcinosis; Idiopathic basal ganglia calcification; Keutel syndrome; Phenotype; Pseudoxanthoma elasticum; Pseudoxanthoma elasticum-like syndrome

Year:  2015        PMID: 26244149      PMCID: PMC4517332          DOI: 10.12998/wjcc.v3.i7.556

Source DB:  PubMed          Journal:  World J Clin Cases        ISSN: 2307-8960            Impact factor:   1.337


  165 in total

Review 1.  Pseudoxanthoma elasticum, ocular manifestations, complications and treatment.

Authors:  Ilias Georgalas; Ioannis Tservakis; Dimitris Papaconstaninou; Marina Kardara; Chryssanthi Koutsandrea; Ioannis Ladas
Journal:  Clin Exp Optom       Date:  2010-12-29       Impact factor: 2.742

Review 2.  Idiopathic infantile arterial calcification: two case reports, a review of the literature and a role for cardiac transplantation.

Authors:  Andrew C Glatz; Bruce R Pawel; Daphne T Hsu; Paul Weinberg; Maryanne R K Chrisant
Journal:  Pediatr Transplant       Date:  2006-03

3.  Singleton-Merten syndrome: an autosomal dominant disorder with variable expression.

Authors:  Annette Feigenbaum; Christine Müller; Christopher Yale; Johannes Kleinheinz; Peter Jezewski; Hans Gerd Kehl; Mary MacDougall; Frank Rutsch; Raoul C M Hennekam
Journal:  Am J Med Genet A       Date:  2013-01-15       Impact factor: 2.802

4.  Calcification in the basal ganglia with chronic active Epstein-Barr virus infection.

Authors:  M Morita; I Tsuge; H Matsuoka; Y Ito; T Itosu; M Yamamoto; T Morishima
Journal:  Neurology       Date:  1998-05       Impact factor: 9.910

5.  Keutel syndrome: clinical report and literature review.

Authors:  E J Cormode; M Dawson; R B Lowry
Journal:  Am J Med Genet       Date:  1986-06

6.  ABCC6-mediated ATP secretion by the liver is the main source of the mineralization inhibitor inorganic pyrophosphate in the systemic circulation-brief report.

Authors:  Robert S Jansen; Suzanne Duijst; Sunny Mahakena; Daniela Sommer; Flóra Szeri; András Váradi; Astrid Plomp; Arthur A Bergen; Ronald P J Oude Elferink; Piet Borst; Koen van de Wetering
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-06-26       Impact factor: 8.311

Review 7.  Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade.

Authors:  Gennady G Yegutkin
Journal:  Biochim Biophys Acta       Date:  2008-02-12

8.  Pseudoxanthoma Elasticum Treatment with Fractional CO2 Laser.

Authors:  Alessandra Grassi Salles; Adelina Fátima do Nascimento Remigio; Luciana Borsoi Moraes; Andreza Cristina Camacho Varoni; Rolf Gemperli; Marcus Castro Ferreira
Journal:  Plast Reconstr Surg Glob Open       Date:  2014-10-07

9.  Pseudoxanthoma elasticum of the skin with involvement of the oral cavity.

Authors:  Flávia Sayuri Matsuo; Alceu Luiz Camargo Villela Berbert; Sônia Antunes de Oliveira Mantese; Adriano Mota Loyola; Sérgio Vitorino Cardoso; Paulo Rogério de Faria
Journal:  Case Rep Dent       Date:  2013-05-18

Review 10.  Tophaceous gout - even today.

Authors:  Elena Polukhin; Jaya Durvasula
Journal:  Front Immunol       Date:  2013-09-23       Impact factor: 7.561

View more
  15 in total

Review 1.  Monckeberg's Medial Sclerosis as a Cause for Headache and Facial Pain.

Authors:  Davis C Thomas; Prisly Thomas; Anilkumar Sivan; Priyanka Unnam; Ahana Ajayakumar; Sanjana Santhosh Kumar; Priyanka Kodaganallur Pitchumani; Mahnaz Fatahzadeh; Nida-E-Haque Mahmud
Journal:  Curr Pain Headache Rep       Date:  2021-06-04

2.  Serum Calcification Propensity T50 Associates with Disease Severity in Patients with Pseudoxanthoma Elasticum.

Authors:  Lukas Nollet; Matthias Van Gils; Suzanne Fischer; Laurence Campens; Swapna Karthik; Andreas Pasch; Julie De Zaeytijd; Bart P Leroy; Daniel Devos; Tine De Backer; Paul J Coucke; Olivier M Vanakker
Journal:  J Clin Med       Date:  2022-06-28       Impact factor: 4.964

Review 3.  Auricular ossification: A newly recognized feature of osteoprotegerin-deficiency juvenile Paget disease.

Authors:  Gary S Gottesman; Katherine L Madson; William H McAlister; Angela Nenninger; Deborah Wenkert; Steven Mumm; Michael P Whyte
Journal:  Am J Med Genet A       Date:  2016-01-14       Impact factor: 2.802

4.  Mutation spectrum in the ABCC6 gene and genotype-phenotype correlations in a French cohort with pseudoxanthoma elasticum.

Authors:  Anne Legrand; Laurence Cornez; Wafa Samkari; Jean-Michael Mazzella; Annabelle Venisse; Valérie Boccio; Karine Auribault; Boris Keren; Karelle Benistan; Dominique P Germain; Michael Frank; Xavier Jeunemaitre; Juliette Albuisson
Journal:  Genet Med       Date:  2017-01-19       Impact factor: 8.822

5.  Bilateral calcification of the optic nerve sheath: A diagnostic dilemma.

Authors:  Yngvil Solheim Husum; Karoline Skogen; Petter Brandal; Pål Andre Rønning; Andreas Reidar Wigers; Johan Arild Evang; Øystein Kalsnes Jørstad
Journal:  Am J Ophthalmol Case Rep       Date:  2021-04-22

6.  HMGB1 Induces Secretion of Matrix Vesicles by Macrophages to Enhance Ectopic Mineralization.

Authors:  Qiang Chen; Jun-Jie Bei; Chuan Liu; Shi-Bin Feng; Wei-Bo Zhao; Zhou Zhou; Zheng-Ping Yu; Xiao-Jun Du; Hou-Yuan Hu
Journal:  PLoS One       Date:  2016-05-31       Impact factor: 3.240

Review 7.  Pseudoxanthoma elasticum.

Authors:  Dominique P Germain
Journal:  Orphanet J Rare Dis       Date:  2017-05-10       Impact factor: 4.123

Review 8.  GGCX-Associated Phenotypes: An Overview in Search of Genotype-Phenotype Correlations.

Authors:  Eva Y G De Vilder; Jens Debacker; Olivier M Vanakker
Journal:  Int J Mol Sci       Date:  2017-01-25       Impact factor: 5.923

9.  Magnesium and Anti-phosphate Treatment with Bisphosphonates for Generalised Arterial Calcification of Infancy: A Case Report

Authors:  Fatma Dursun; Tülay Atasoy Öztürk; Serçin Güven; Heves Kırmızıbekmez; Gülcan Seymen Karabulut; Sevinç Kalın; Betül Sözeri
Journal:  J Clin Res Pediatr Endocrinol       Date:  2018-12-11

Review 10.  The Role of Vitamin K and Its Related Compounds in Mendelian and Acquired Ectopic Mineralization Disorders.

Authors:  Lukas Nollet; Matthias Van Gils; Shana Verschuere; Olivier Vanakker
Journal:  Int J Mol Sci       Date:  2019-04-30       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.